#United States #New York #Securities Fraud #Dentsply Sirona #XRAY

Dentsply Sirona Securities Fraud Class Action

In a recent reminder from the Rosen Law Firm, potential claimants are being urged to take action regarding a securities fraud lawsuit involving Dentsply Sirona Inc. (NASDAQ: XRAY). Investors who purchased common stock during the class period, from December 1, 2022, to November 6, 2024, are informed of a pivotal deadline for lead plaintiff applications on January 27, 2025. This class action is a significant opportunity for investors who believe they have been misled by the company's representations and are seeking restitution.

Background of the Case

Dentsply Sirona, a leading global dental company, has faced scrutiny regarding its business practices. The class action claims that the company issued false or misleading statements about its operations and patient safety standards. It alleges that during the specified period, Dentsply knowingly targeted low-income patients with limited access to dental care, leading to an increase in patient injuries associated with their Byte dental aligners. These claims highlight a concerning trend where sales goals overshadowed patient safety.

What Investors Need to Know

Investors who purchased Dentsply Sirona common stock during the class period may be eligible for compensation without upfront costs through a contingency fee arrangement. This means that affected investors can seek redress without incurring legal fees unless they win the case.

To participate in this class action, potential plaintiffs can join by visiting the Rosen Law Firm’s website or contacting their office directly. However, to serve as the lead plaintiff, an individual must file a motion by the upcoming deadline of January 27, 2025. The lead plaintiff plays a critical role in representing the interests of all class members throughout the litigation process.

The Importance of Qualified Counsel

The Rosen Law Firm emphasizes the importance of choosing experienced legal representation in securities class actions. Many other firms may not possess the same level of expertise or resources to effectively advocate for investors' rights. With a solid track record of successful settlements and recognized capabilities in class action litigation, the Rosen Law Firm stands out as a reliable advocate for investors.

Key Allegations Against Dentsply Sirona

According to the lawsuit, Dentsply Sirona’s defendants failed to adequately protect its patients by

1. Not disclosing that Byte aligners were marketed to patients who were not suitable candidates for treatment, leading to adverse health outcomes.
2. Intensifying sales tactics that compromised patient safety for the sake of growth and commission incentives.
3. Neglecting to report serious injuries and not developing the necessary protocols to alert the FDA of the issues, which they were legally obligated to do.

The cumulative effect of these actions purportedly resulted in significant financial and health consequences for both the company and its investors, stemming from a decline in trust and subsequent legal repercussions once the facts came to light.

Conclusion

As the January 27, 2025, deadline looms, affected investors are encouraged to take action to protect their rights and pursue potential compensation. For more information about joining the class action or to discuss the specifics of the claims, interested parties can reach out to Phillip Kim, Esq., at the Rosen Law Firm. This case could represent a pivotal moment for those affected by the alleged misconduct of Dentsply Sirona, offering an opportunity to reclaim losses incurred during the class period.

Stay updated on developments regarding this case by following the Rosen Law Firm on LinkedIn, Twitter, and Facebook. Remember, time is of the essence, and investors must act swiftly to ensure their voices are heard in this significant legal battle.